Dutch senior adviser confirmed as new Philips regulatory expert
This article was originally published in SRA
Sabina Hoekstra van den Bosch, senior adviser at the Dutch government’s Department of Pharmaceutical Affairs and Medical Technology, has accepted a position at Philips Healthcare as senior manager, quality and regulatory1. She will be leaving her current post at the Dutch Ministry of Health, Welfare and Sport – a position she has held for nine years – on 1 October 2011. Ms Hoekstra van den Bosch is vice-chair of the recently established European Central Management Committee (CMC) on medical devices and was chair of the EU Working Group on New and Emerging Technologies in Medical Devices for four years, up until December 2009.
You may also be interested in...
The European Parliament is about to sign off corrigenda to the Medical Devices and IVD Regulations. The headline news is a longer transition period for a huge swathe of class I products, but there are other changes too.
The two-year delay to Eudamed was a Commission decision. Now the competent authorities are fighting back and the issue is to be discussed at the level of the Council of the European Union on December 9 to avoid “heavily burdensome administrative transitional solutions.”
With six months left to the full implementation of the EU’s Medical Devices Regulation, there are a couple of big shifts taking place in the way it is being applied. Following news of the Eudamed database two-year delay, confirmation looks imminent that many more products will avoid having to comply with the MDR by next May. But will this plan sufficiently alleviate implementation pressures?